Telomere dynamics in cancer progression and prevention: Fundamental differences in human and mouse telomere biology

Nature Medicine

Volumn 6, Issue 8, 2000, Pages 849-851

  Wright, Woodring E ^a   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CANCER GROWTH; CANCER PREVENTION; CATALYSIS; CELL DIVISION; DNA DAMAGE; ENZYME DEFICIENCY; GROWTH DISORDER; HYPOTHESIS; KNOCKOUT MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; TELOMERE;

ANIMALS; CELL AGING; CELL DIVISION; FIBROBLASTS; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASMS; SPECIES SPECIFICITY; TELOMERASE; TELOMERE;

ANIMALIA;

EID: 0033834247     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/78592     Document Type: Review

References (35)

1. Hayflick, L. & Moorhead, P.S. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 25, 585-621 (1961).
2. Wright, W.E. & Shay, J.W. The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol. 27, 383-389 (1992).
3. Harley, C.B. Telomere loss: mitotic clock or genetic time bomb? Mutat. Res. 256, 271-282 (1991).
4. Shay, J.W., Pereira-Smith, O.M. & Wright, W.E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196, 33-39 (1991).
5. Hara, E., Tsurui, H., Shinozaki, A., Nakada, S. & Oda, K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179, 528-534 (1991).
6. Bodnar, A.G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998).
7. Vaziri, H. & Benchimol, S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279-282 (1998).
8. Wright, W.E., Brasiskyte, D., Piatyszek, M.A. & Shay, J.W. Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J. 15, 1734-1741 (1996).
9. Counter, C.M. et al. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA 95, 14723-14728 (1998).
10. Halvorsen, T.L., Leibowitz, G. & Levine, F. Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol. Cell. Biol. 19, 1864-1870 (1999).
11. Zhu, J., Wang, H., Bishop, J.M. & Blackburn, E.H. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. USA 96, 3723-3728 (1999).
12. Blasco, M.A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34 (1997).
13. Zalvide, J. & DeCaprio, J.A. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15, 5800-5810 (1995).
14. Kamijo, T. et al. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. Cancer Res. 59, 2464-2469 (1999).
15. Sherr, C.J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984-2991 (1998).
16. Robles, S.J. & Adami, G.R. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16, 1113-1123 (1998).
17. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. & Lowe, S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
18. Zhu, J., Woods, D., McMahon, M. & Bishop, J.M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12, 2997-3007 (1998).
19. Rubin, H. Cell aging in vivo and in vitro. Mech. Ageing Dev. 98, 1-35 (1997).
20. Loo, D.T., Fuquay, J.I., Rawson, C.L. & Barnes, D.W. Extended culture of mouse embryo cells without senescence: inhibition by serum. Science 236, 200-202 (1987).
21. Nussenzweig, A. et al. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382, 551-555 (1996).
22. Barlow, C. et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159-171 (1996).
23. Xu, Y. & Baltimore, D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev. 10, 2401-2410 (1996).
24. Connor, F. et al. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nature Genet. 17, 423-430 (1997).
25. Westphal, C.H. et al. Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res. 57, 1664-1667 (1997).
26. Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527-538 (1999).
27. Greenberg, R.A. et al. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 97, 515-525 (1999).
28. Shay, J.W. & Wright, W.E. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp. Cell Res. 184, 109-118 (1989).
29. Shay, J.W., Van der Haegen, B.A., Ying, Y. & Wright, W.E. The frequency of immortalization of human fibroblast and mammary epithelial cells transfected with SV40 large T-antigen. Exp. Cell Res. 209, 45-52 (1993).
30. Kiyono, T. et al. Both Rb/p16ink4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88 (1998).
31. Shay, J.W., Tomlinson, G., Piatyszek, M.A. & Gollahon, L.S. Spontaneous in vitro immortalization of breast epithelial cells from a Li-Fraumeni patient. Mol. Cell. Biol. 15, 425-432 (1995).
32. de Lange, T. & Jacks, T. For better or worse? Telomerase inhibition and cancer. Cell 98, 273-275 (1999).
33. Hahn, W.C. et al. Inhibition of telomerase limits the growth of human cancer cells. Nature Med. 5, 1164-1170 (1999).
34. Herbert, B-S et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Nat. Acad. Sci. USA 96, 14276-14281 (1999).
35. Holt, S.E., Wright, W.E. & Shay, J.W. Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol. 16, 2932-2939 (1996).